The Center for Reproductive Health Sciences is thrilled to announce that research from the lab of Dineo Khabele, MD, was recently published in BMC Cancer. The research article is titled “The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model” and was authored by Gupta et al. The researchers of this study concluded that “Rebastinib […]
Khabele Lab Unveils New Strategy to Reduce Ovarian Cancer Growth
